Meeting Coverage
ASCO Future Focus: NSCLC
Future Focus from the American Society of Clinical Oncology
Latest ASCO Future Focus: NSCLC Meeting Coverage
Patients by far prefer subcutaneous to intravenous medication delivery, says Jorge Nieva, MD
August 6, 2024
Streamlined approach broadens eligibility and reduces site burden
July 30, 2024
And minimal residual disease analysis may help determine length of therapy
July 23, 2024
Latest Oncology/Hematology Meeting Coverage
-
SNO: Society for NeuroOncology
November 2024
-
ASTRO: American Society for Radiation Oncology
September 2024
-
ESMO: European Society for Medical Oncology
September 2024
-
ASCO: American Society of Clinical Oncology
May 2024